Larson Financial Group’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.71K | Buy |
125
+114
| +1,036% | +$2.47K | ﹤0.01% | 2291 |
|
|
2025
Q1 | $267 | Sell |
11
-2,340
| -100% | -$56.8K | ﹤0.01% | 2708 |
|
|
2024
Q4 | $49.1K | Sell |
2,351
-654
| -22% | -$13.6K | ﹤0.01% | 905 |
|
|
2024
Q3 | $59.7K | Buy |
3,005
+2,994
| +27,218% | +$59.5K | ﹤0.01% | 847 |
|
|
2024
Q2 | $170 | Buy |
+11
| New | +$170 | ﹤0.01% | 2108 |
|
|
2023
Q2 | – | Sell |
-1
| Closed | -$17 | – | 1576 |
|
|
2023
Q1 | $17 | Hold |
1
| – | – | ﹤0.01% | 1526 |
|
|
2022
Q4 | $19 | Buy |
+1
| New | +$19 | ﹤0.01% | 1485 |
|